Global Proteomic Biomarker Analytics Market Report 2023 with Executive & Consultant Guides - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to ResearchAndMarkets.com's offering.

Proteomics is going mainstream. Where genomics couldn't find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is to understand the front line players, the actual proteins and protein complexes, that do the work of managing cellular life.

Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time.

This research makes you the expert in your organization. All report data is available in Excel format on request. Assistance, and additional specific data, is provided without additional charges. Make investment decisions and valuations with confidence using the latest data.

The report forecasts the market size out for five years for a number of different market segments.

Key Topics Covered:

1 Market Guides

1.1 Situation Analysis

1.2 Guide for Executives and Marketing Staff

1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

2.1 What is Proteomic Biomarker Analytics?

2.2 Proteomics and Drug Development

2.3 Market Definition

2.3.1 Market Size

2.3.2 Currency

2.3.3 Years

2.4 Methodology

2.4.1 Methodology

2.4.2 Sources

2.4.3 Authors

3 Proteomic Biomarker Analytics - Guide to Technologies

3.1 Methods

3.1.1 Separation techniques and electrophoresis

3.1.2 Mass spectrometry

3.1.3 Chromatography

3.1.4 Blotting

3.1.5 Protein complementation assays and interaction screens

3.1.6 Protein structure prediction

3.1.7 Protein databases

4 Industry Overview

4.1 Players in a Dynamic Market

4.2 Academic Research Lab

4.3 Diagnostic Test Developer

4.4 Instrumentation Supplier

4.5 Chemical/Reagent Supplier

4.6 Pathology Supplier

4.7 Independent Clinical Laboratory

4.8 Public National/regional Laboratory

4.9 Hospital Laboratory

4.10 Physicians Office Lab (POLS)

4.11 Audit Body

4.12 Certification Body

5 Market Trends

5.1 Factors Driving Growth

5.1.1 Drug Development

5.1.2 Companion Dx

5.1.3 Fertile Research

5.1.4 Technology Convergence

5.2 Factors Limiting Growth

5.2.1 The Cost Curve

5.2.2 Capacity Constraints

5.2.3 Market Lag

6 Proteomic Analytics Recent Developments

6.1 Recent Developments - Importance and How to Use This Section

6.1.1 Importance of These Developments

6.1.2 How to Use This Section

6.2 Amprion's Parkinson's Disease Dx Shows Strong Performance

6.3 Single-Cell Proteomics Bypasses Bottlenecks

6.4 SomaLogic Seeks 'Strategic Alternatives' for Dx Business

6.5 Alzheimer's Dx Study to Add Genomic, Proteomic Profiling

6.6 NanoDx Prepares for POC Platform Commercialization

6.7 DeepMind AI Predicts 3D Structure of Every Protein

6.8 Quanterix Slashing Workforce by 25 Percent

6.9 Study Shows Potential of NanoMosaic's Platform for Biomarker Development

6.10 Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of OmicEra

6.11 PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications

6.12 Octave Bioscience Building Evidence Base for Multiple Sclerosis Test

6.13 Proteomics Goes Public

7 Profiles of Key Proteomic Biomarker Analytic Companies

7.1 Abbott Laboratories

7.2 Agilent/Dako

7.3 Amprion

7.4 BasePair Biotechnologies

7.5 Beckman Coulter Diagnostics

7.6 Becton, Dickinson and Company

7.7 Bio-Rad Laboratories, Inc.

7.8 Bio-Techne

7.9 Bruker

7.10 C2N Diagnostics

7.11 Cepheid (Danaher)

7.12 Diadem Diagnostics

7.13 Eve Technologies

7.14 Fluidic Analytics

7.15 Fujirebio

7.16 Hybrigenics Services

7.17 Luminex Corp (DiaSorin)

7.18 NanoDx

7.19 Nautilus Biotechnology

7.20 Nicoya

7.21 Olink

7.22 Qiagen

7.23 Quanterix

7.24 Roche Molecular Diagnostics

7.25 Second Genome

7.26 Siemens Healthineers

7.27 Somalogic

7.28 Thermo Fisher Scientific Inc.

8 Global Proteomic Analytics Markets

8.1 Protein Analytics - Global Market Overview by Country

8.2 Global Market by Application - Overview

8.3 Global Market by Technology - Overview

8.4 Global Market by Product - Overview

8.5 Global Market by Place - Overview

9 Global Protein Analytics Markets - By Application

9.1 Protein Analytics Drug Discovery

9.2 Protein Analytics Research Application

9.3 Protein Analytics Clinical Dx

9.4 Protein Analytics Other Applications

10 Global Protein Analytics Markets - By Technology

10.1 Protein Analytics Mass Spectrometry

10.2 Protein Analytics ELISA/Beads

10.3 Protein Analytics Hybrid Multiplex

10.4 Protein Analytics Other Technology

11 Global Protein Analytics Markets - By Product

11.1 Protein Analytics Instruments

11.2 Protein Analytics Kits & Reagents

11.3 Protein Analytics Services

12 Global Protein Analytics Markets - By Place

12.1 Protein Analytics Academic

12.2 Protein Analytics Pharma/Biotech

12.3 Protein Analytics Clinical

12.4 Protein Analytics Other Place

For more information about this report visit https://www.researchandmarkets.com/r/2yyars

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900